December 19, 2017: Aegle announces the appointment of Dr. Robert Ryan, CEO of Innova Therapeutics, to its board of directors. [Click for Press Release]




December 15, 2017: Aegle to present at the Biotech Showcase in San Francisco on Tuesday January 9, 2018 at 11am.




December 15, 2017: Aegle to participate in panel discussion at the Biotech Showcase In San Francisco on Monday January 8, 2018 from 9:00am-10:00am entitled, “Dermatology – More than Skin Deep.”




November 1, 2017: Aegle announces the addition of Dr. Ian McNiece to our senior management team as Vice President of Research and Development.




December 2016: Aegle files an IND with the FDA for the treatment of burns/scarring using allogeneic extracellular vesicles.




March 2016: Aegle Therapeutics is selected for Springboard’s 2016 Health Innovation Hub.




February 2015: Aegle Therapeutics signs an exclusive license from the University of Miami (Miami, FL) for the rights to extracellular vesicle isolation technology and the use of extracellular vesicles isolated using the proprietary process for therapeutic and diagnostic indications.